Brazil’s President Luiz Inácio Lula da Silva arrived on Thursday in Mozambique to launch a project to make antiretrovirals in the Southern African country, the foreign ministry said.
Brazil, long considered a model in the fight against HIV/Aids, will invest $23-million to build a factory to produce generic antiretrovirals, the foreign ministry said.
Lula will sign the deal launching the project on Friday, with production of drugs expected to begin before the end of 2009.
He is also due to preside over the opening of an office for the Oswaldo Cruz Foundation, known as Fiocruz, which is managing the project.
The factory will be built with Brazilian technology, but the raw materials to produce the drugs will come from India.
”Brazil plans to invest $23-million in four phases in the Maputo factory. About $4-million has been earmarked for the first stage of the project, and that money will be available by the end of this year,” the foreign ministry spokesperson said, speaking on condition of anonymity.
The factory will produce eight antiretroviral drugs. Mozambican technicians will be trained by Farmanguinhos, a Fiocruz laboratory, which is attached to the Brazilian health ministry.
When the two countries signed the deal last month, Brazilian authorities said they planned for the factory to supply drugs across Africa.
According to government figures, Mozambique’s HIV prevalence rate among the 16-to-49 age group is estimated at more than 16%.
Experts once feared that Brazil could suffer a similarly severe pandemic, but now only 0,61% of Brazilians in the same age bracket are infected with HIV/Aids.
Brazil has undertaken aggressive prevention programmes and about one-third of Brazilians living with HIV/Aids receive free treatment. – AFP
